Australian Securities and Investments Commission Reporting

The Australian Securities and Investments Commission (ASIC) introduced its version of the OTC Derivative Transaction Reporting regime for Australia in July 2013. This regulation sets out the requirements for reporting entities to report derivative transaction information to trade repositories.

What is ASIC Reporting?

Entities caught under the ASIC rules have a legal obligation to provide a set of prescribed data related to the activities that they are undertaking within the financial markets. Similar to EMIR reporting, ASIC requires lifecycle and position reporting.

ASIC’s set of prescribed data can also be split broadly into the following categories:

  • Transaction Information – UTI , counterparty, execution timestamp etc
  • Collateral Data – master agreements, collateralisation type etc
  • Trade Economics – notional, price, currency, maturity date etc.

Similar to other OTC derivative reporting regimes such as CFTC, MAS and EMIR, the ASIC regime has undergone numerous iterations with the latest rewrite due to commence in October 2024. This will introduce a significant amount of change as a result of the regulator’s efforts towards global harmonisation and streamlining of derivative data reported under this regime.

How we can help

Our ReportShield™ quality assurance services give you the ability to demonstrate appropriate controls over your reporting obligations for ASIC across all five derivative asset classes. We can also conduct cross-regulation testing to ensure consistency with other regimes and provide remediation of reports.

Accuracy Testing

The testing gold standard, providing the maximum level of protection against regulatory challenge. Learn more

Advanced Regulatory Reconciliation

Our end-to-end reconciliation service tests for the completeness of regulatory reporting. Learn more

Control Framework

Together with data quality, a robust control framework is a key expectation of regulators. Learn more

Is your ASIC reporting accurate and complete?

For a free healthcheck of your reporting or a conversation with one of our regulatory specialists, please fill in the form below.

* indicates required fields

Newsletter Consent
This field is for validation purposes and should be left unchanged.